The rules made by the division under Subsection 58-17b-903(2)(b) shall include:
(1)registration requirements to establish the eligibility of a pharmacy to participate in the program;
(2)a formulary that includes all eligible prescription drugs approved by the federal Food and Drug Administration;
(3)standards and procedures for:
(3)(a) verifying whether a pharmacy or pharmacist participating in the program is licensed and in good standing with the board;
(3)(b) handling of an eligible prescription drug transferred in accordance with Subsection 58-17b-903(2) to an eligible pharmacy or a physician's office, including:
(3)(b)(i) acceptance;
(3)(b)(ii) identification, including redundant criteria for verification;
(3)(b)(iii) documentation, under 21 U.S.C. Sec. 360eee-1, of transaction inf
Free access — add to your briefcase to read the full text and ask questions with AI
The rules made by the division under Subsection 58-17b-903(2)(b) shall include:
(1) registration requirements to establish the eligibility of a pharmacy to participate in the program;
(2) a formulary that includes all eligible prescription drugs approved by the federal Food and Drug Administration;
(3) standards and procedures for:
(3)(a) verifying whether a pharmacy or pharmacist participating in the program is licensed and in good standing with the board;
(3)(b) handling of an eligible prescription drug transferred in accordance with Subsection 58-17b-903(2) to an eligible pharmacy or a physician's office, including:
(3)(b)(i) acceptance;
(3)(b)(ii) identification, including redundant criteria for verification;
(3)(b)(iii) documentation, under 21 U.S.C. Sec. 360eee-1, of transaction information, history, and statements;
(3)(b)(iv) safe storage;
(3)(b)(v) security;
(3)(b)(vi) inspection;
(3)(b)(vii) transfer; and
(3)(b)(viii) dispensing;
(3)(c) a pharmacist, pharmacy intern, or licensed pharmacy technician:
(3)(c)(i) working in or consulting with a participating eligible donor; or
(3)(c)(ii) assisting an individual donating the eligible prescription drug;
(3)(d) disposition of a donated prescription drug that is a controlled substance;
(3)(e) record keeping regarding:
(3)(e)(i) the individual or eligible donor that transferred an eligible prescription drug under Subsection 58-17b-903(2)(a);
(3)(e)(ii) the identification and evaluation of a donated prescription drug by a pharmacist or licensed pharmacy technician; and
(3)(e)(iii) the dispensing or disposition of a prescription drug;
(3)(f) determining the status of a medically indigent individual;
(3)(g) labeling requirements to:
(3)(g)(i) ensure compliance with patient privacy laws relating to:
(3)(g)(i)(A) an individual who receives an eligible prescription drug; and
(3)(g)(i)(B) patient information that may appear on a donated prescription drug;
(3)(g)(ii) clearly identify an eligible prescription drug dispensed under the program; and
(3)(g)(iii) communicate necessary information regarding the manufacturer's recommended expiration date or the beyond use date; and
(3)(h) ensuring compliance with the requirements of this part;
(4) a process for seeking input from the Department of Health and Human Services created in Section 26B-1-201 to:
(4)(a) establish program standards and procedures for assisted living facilities and nursing care facilities; and
(4)(b) establish program standards and procedures for mental health and substance abuse clients; and
(5) the creation of a special training program that a pharmacist and a licensed pharmacy technician at an eligible pharmacy must complete before participating in the program.